1-16 of 16
John R. Wunderlich
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus–associated Epithelial Cancers

Available to Purchase
Sanja Stevanović, Sarah R. Helman, John R. Wunderlich, Michelle M. Langhan, Stacey L. Doran, Mei Li M. Kwong, Robert P.T. Somerville, Christopher A. Klebanoff, Udai S. Kammula, Richard M. Sherry, James C. Yang, Steven A. Rosenberg, Christian S. Hinrichs
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (5): 1486–1493.
https://doi.org/10.1158/1078-0432.CCR-18-2722
Published: 01 March 2019
View articletitled, A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus–associated Epithelial Cancers
Open the PDF for A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus–associated Epithelial Cancers in another window
Includes: Supplementary data
Journal Articles

T-cell Responses to TP53 “Hotspot” Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers

Free
Drew C. Deniger, Anna Pasetto, Paul F. Robbins, Jared J. Gartner, Todd D. Prickett, Biman C. Paria, Parisa Malekzadeh, Li Jia, Rami Yossef, Michelle M. Langhan, John R. Wunderlich, David N. Danforth, Robert P.T. Somerville, Steven A. Rosenberg
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (22): 5562–5573.
https://doi.org/10.1158/1078-0432.CCR-18-0573
Published: 15 November 2018
View articletitled, T-cell Responses to TP53 “Hotspot” Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers
Open the PDF for T-cell Responses to TP53 “Hotspot” Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers in another window
Includes: Supplementary data
Journal Articles

Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer

Available to Purchase
Yasmine Assadipour, Nikolaos Zacharakis, Jessica S. Crystal, Todd D. Prickett, Jared J. Gartner, Robert P.T. Somerville, Hui Xu, Mary A. Black, Li Jia, Harshini Chinnasamy, Isaac Kriley, Lily Lu, John R. Wunderlich, Zhili Zheng, Yong-Chen Lu, Paul F. Robbins, Steven A. Rosenberg, Stephanie L. Goff, Steven A. Feldman
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (15): 4347–4353.
https://doi.org/10.1158/1078-0432.CCR-16-1423
Published: 01 August 2017
View articletitled, Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer
Open the PDF for Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma

Available to Purchase
Drew C. Deniger, Mei Li M. Kwong, Anna Pasetto, Mark E. Dudley, John R. Wunderlich, Michelle M. Langhan, Chyi-Chia Richard Lee, Steven A. Rosenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (2): 351–362.
https://doi.org/10.1158/1078-0432.CCR-16-0906
Published: 15 January 2017
View articletitled, A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma
Open the PDF for A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma in another window
Journal Articles

Identification of an Immunogenic Subset of Metastatic Uveal Melanoma

Available to Purchase
Luke D. Rothermel, Arvind C. Sabesan, Daniel J. Stephens, Smita S. Chandran, Biman C. Paria, Abhishek K. Srivastava, Robert Somerville, John R. Wunderlich, Chyi-Chia R. Lee, Liqiang Xi, Trinh H. Pham, Mark Raffeld, Parthav Jailwala, Manjula Kasoji, Udai S. Kammula
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (9): 2237–2249.
https://doi.org/10.1158/1078-0432.CCR-15-2294
Published: 01 May 2016
View articletitled, Identification of an Immunogenic Subset of Metastatic Uveal Melanoma
Open the PDF for Identification of an Immunogenic Subset of Metastatic Uveal Melanoma in another window
Includes: Supplementary data
Journal Articles

A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response

Available to Purchase
Paul F. Robbins, Sadik H. Kassim, Thai L.N. Tran, Jessica S. Crystal, Richard A. Morgan, Steven A. Feldman, James C. Yang, Mark E. Dudley, John R. Wunderlich, Richard M. Sherry, Udai S. Kammula, Marybeth S. Hughes, Nicholas P. Restifo, Mark Raffeld, Chyi-Chia R. Lee, Yong F. Li, Mona El-Gamil, Steven A. Rosenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (5): 1019–1027.
https://doi.org/10.1158/1078-0432.CCR-14-2708
Published: 01 March 2015
View articletitled, A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
Open the PDF for A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response in another window
Includes: Supplementary data
Journal Articles

Persistence of CTL Clones Targeting Melanocyte Differentiation Antigens Was Insufficient to Mediate Significant Melanoma Regression in Humans

Available to Purchase
Smita S. Chandran, Biman C. Paria, Abhishek K. Srivastava, Luke D. Rothermel, Daniel J. Stephens, Mark E. Dudley, Robert Somerville, John R. Wunderlich, Richard M. Sherry, James C. Yang, Steven A. Rosenberg, Udai S. Kammula
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (3): 534–543.
https://doi.org/10.1158/1078-0432.CCR-14-2208
Published: 01 February 2015
View articletitled, Persistence of CTL Clones Targeting Melanocyte Differentiation Antigens Was Insufficient to Mediate Significant Melanoma Regression in Humans
Open the PDF for Persistence of CTL Clones Targeting Melanocyte Differentiation Antigens Was Insufficient to Mediate Significant Melanoma Regression in Humans in another window
Includes: Supplementary data
Journal Articles

Human Melanoma Metastases Demonstrate Nonstochastic Site-Specific Antigen Heterogeneity That Correlates with T-cell Infiltration

Available to Purchase
Edmund K. Bartlett, Patricia A. Fetsch, Armando C. Filie, Andrea Abati, Seth M. Steinberg, John R. Wunderlich, Donald E. White, Daniel J. Stephens, Francesco M. Marincola, Steven A. Rosenberg, Udai S. Kammula
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (10): 2607–2616.
https://doi.org/10.1158/1078-0432.CCR-13-2690
Published: 14 May 2014
View articletitled, Human Melanoma Metastases Demonstrate Nonstochastic Site-Specific Antigen Heterogeneity That Correlates with T-cell Infiltration
Open the PDF for Human Melanoma Metastases Demonstrate Nonstochastic Site-Specific Antigen Heterogeneity That Correlates with T-cell Infiltration in another window
Includes: Supplementary data
Journal Articles

Tumor-Reactive CD8+ T Cells in Metastatic Gastrointestinal Cancer Refractory to Chemotherapy

Available to Purchase
Simon Turcotte, Alena Gros, Eric Tran, Chyi-Chia R. Lee, John R. Wunderlich, Paul F. Robbins, Steven A. Rosenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (2): 331–343.
https://doi.org/10.1158/1078-0432.CCR-13-1736
Published: 16 January 2014
View articletitled, Tumor-Reactive CD8+ T Cells in Metastatic Gastrointestinal Cancer Refractory to Chemotherapy
Open the PDF for Tumor-Reactive CD8+ T Cells in Metastatic Gastrointestinal Cancer Refractory to Chemotherapy in another window
Includes: Supplementary data
Journal Articles

Gene Expression Profiling using Nanostring Digital RNA Counting to Identify Potential Target Antigens for Melanoma Immunotherapy

Available to Purchase
Rachel E. Beard, Daniel Abate-Daga, Shannon F. Rosati, Zhili Zheng, John R. Wunderlich, Steven A. Rosenberg, Richard A. Morgan
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (18): 4941–4950.
https://doi.org/10.1158/1078-0432.CCR-13-1253
Published: 16 September 2013
View articletitled, Gene Expression Profiling using Nanostring Digital RNA Counting to Identify Potential Target Antigens for Melanoma Immunotherapy
Open the PDF for Gene Expression Profiling using Nanostring Digital RNA Counting to Identify Potential Target Antigens for Melanoma Immunotherapy in another window
Includes: Supplementary data
Journal Articles

Myeloid Cells Obtained from the Blood but Not from the Tumor Can Suppress T-cell Proliferation in Patients with Melanoma

Available to Purchase
Alena Gros, Simon Turcotte, John R. Wunderlich, Mojgan Ahmadzadeh, Mark E. Dudley, Steven A. Rosenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (19): 5212–5223.
https://doi.org/10.1158/1078-0432.CCR-12-1108
Published: 30 September 2012
View articletitled, Myeloid Cells Obtained from the Blood but Not from the Tumor Can Suppress T-cell Proliferation in Patients with Melanoma
Open the PDF for Myeloid Cells Obtained from the Blood but Not from the Tumor Can Suppress T-cell Proliferation in Patients with Melanoma in another window
Includes: Supplementary data
Journal Articles

Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy

Available to Purchase
Steven A. Rosenberg, James C. Yang, Richard M. Sherry, Udai S. Kammula, Marybeth S. Hughes, Giao Q. Phan, Deborah E. Citrin, Nicholas P. Restifo, Paul F. Robbins, John R. Wunderlich, Kathleen E. Morton, Carolyn M. Laurencot, Seth M. Steinberg, Donald E. White, Mark E. Dudley
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (13): 4550–4557.
https://doi.org/10.1158/1078-0432.CCR-11-0116
Published: 05 July 2011
View articletitled, Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
Open the PDF for Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy in another window
Includes: Supplementary data
Journal Articles

CD8+ Enriched “Young” Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma

Available to Purchase
Mark E. Dudley, Colin A. Gross, Michelle M. Langhan, Marcos R. Garcia, Richard M. Sherry, James C. Yang, Giao Q. Phan, Udai S. Kammula, Marybeth S. Hughes, Deborah E. Citrin, Nicholas P. Restifo, John R. Wunderlich, Peter A. Prieto, Jenny J. Hong, Russell C. Langan, Daniel A. Zlott, Kathleen E. Morton, Donald E. White, Carolyn M. Laurencot, Steven A. Rosenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (24): 6122–6131.
https://doi.org/10.1158/1078-0432.CCR-10-1297
Published: 16 December 2010
View articletitled, CD8+ Enriched “Young” Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma
Open the PDF for CD8+ Enriched “Young” Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma in another window
Includes: Supplementary data
Journal Articles

A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer

Available to Purchase
Michael H. Kershaw, Jennifer A. Westwood, Linda L. Parker, Gang Wang, Zelig Eshhar, Sharon A. Mavroukakis, Donald E. White, John R. Wunderlich, Silvana Canevari, Linda Rogers-Freezer, Clara C. Chen, James C. Yang, Steven A. Rosenberg, Patrick Hwu
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (20): 6106–6115.
https://doi.org/10.1158/1078-0432.CCR-06-1183
Published: 24 October 2006
View articletitled, A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer
Open the PDF for A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer in another window
Journal Articles

Intralymphatic Dendritic Cell Vaccination Induces Tumor Antigen–Specific, Skin-Homing T Lymphocytes

Available to Purchase
Amelia Grover, Grace J. Kim, Gregory Lizée, Mary Tschoi, Gang Wang, John R. Wunderlich, Steven A. Rosenberg, Sam T. Hwang, Patrick Hwu
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19): 5801–5808.
https://doi.org/10.1158/1078-0432.CCR-05-2421
Published: 04 October 2006
View articletitled, Intralymphatic Dendritic Cell Vaccination Induces Tumor Antigen–Specific, Skin-Homing T Lymphocytes
Open the PDF for Intralymphatic Dendritic Cell Vaccination Induces Tumor Antigen–Specific, Skin-Homing T Lymphocytes in another window
Journal Articles

Recombinant Fowlpox Viruses Encoding the Anchor-modified gp100 Melanoma Antigen Can Generate Antitumor Immune Responses in Patients with Metastatic Melanoma

Available to Purchase
Steven A. Rosenberg, James C. Yang, Douglas J. Schwartzentruber, Patrick Hwu, Suzanne L. Topalian, Richard M. Sherry, Nicholas P. Restifo, John R. Wunderlich, Claudia A. Seipp, Linda Rogers-Freezer, Kathleen E. Morton, Sharon A. Mavroukakis, Linda Gritz, Dennis L. Panicali, Donald E. White
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (8): 2973–2980.
Published: 11 August 2003
View articletitled, Recombinant Fowlpox Viruses Encoding the Anchor-modified gp100 Melanoma Antigen Can Generate Antitumor Immune Responses in Patients with Metastatic Melanoma
Open the PDF for Recombinant Fowlpox Viruses Encoding the Anchor-modified gp100 Melanoma Antigen Can Generate Antitumor Immune Responses in Patients with Metastatic Melanoma in another window